Rheumatology 2003; 42: 117-122
© 2003 British Society for Rheumatology
Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus
Department of Chemical Pathology and
1 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong
Objective. To investigate the correlations among plasma concentrations of nitric oxide (NO), soluble thrombomodulin (sTM) and vascular cell adhesion molecule (sVCAM-1), and whether these three molecules are associated with renal involvement in patients with systemic lupus erythematosus (SLE).
Methods. Plasma NO concentrations of 73 SLE patients (35 with renal disease, RSLE patients; 38 without renal disease, SLE patients) and 28 age- and sex-matched healthy control subjects were measured by the non-enzymatic Griess assay, and sTM and sVCAM-1 by enzyme-linked immunosorbent assay.
Results. In RSLE patients, plasma nitrite concentrations were significantly higher than in control subjects (P=0.009) and correlated positively with plasma sTM, plasma creatinine and urea (all P<0.05). Plasma sTM and sVCAM-1 concentrations were significantly elevated in RSLE and SLE patients (both P<0.0001) compared with controls. Plasma sTM was significantly correlated with plasma sVCAM-1, and both were correlated with plasma creatinine and urea and the SLE Disease Activity Index (all P<0.05).
Conclusion. Elevated plasma NO, sTM, and sVCAM-1 concentrations have significant intercorrelations and are strongly associated with renal involvement in SLE.
KEY WORDS: Systemic lupus erythematosus, Nitric oxide, Thrombomodulin, Vascular cell adhesion molecule, Glomerulonephritis.
Correspondence to: C. W. K. Lam, Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong. E-mail: waikeilam{at}cuhk.edu.hk
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. R. Batuca, P. R. J. Ames, M. Amaral, C. Favas, D. A. Isenberg, and J. Delgado Alves Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus Rheumatology, January 1, 2009; 48(1): 26 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yao, Z. Liu, X Zhang, C. Zheng, H. Chen, C. Zeng, and L. Li Circulating thrombomodulin and vascular cell adhesion molecule-1 and renal vascular lesion in patients with lupus nephritis Lupus, August 1, 2008; 17(8): 720 - 726. [Abstract] [PDF] |
||||
![]() |
C. K. Wong, L. C. W. Lit, L. S. Tam, E. K. Li, and C. W. K. Lam Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus Rheumatology, May 1, 2005; 44(5): 602 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
M J Lewis and D D'Cruz Adhesion molecules, mycophenolate mofetil and systemic lupus erythematosus Lupus, March 1, 2005; 14(3_suppl): s17 - s26. [Abstract] [PDF] |
||||
![]() |
M. Lewis and D. D'Cruz Adhesion molecules, mycophenolate mofetil and systemic lupus erythematosus Lupus, January 1, 2005; 14(1_suppl): s17 - s26. [Abstract] [PDF] |
||||
![]() |
K Dixit and R Ali Role of nitric oxide modified DNA in the etiopathogenesis of systemic lupus erythematosus Lupus, February 1, 2004; 13(2): 95 - 100. [Abstract] [PDF] |
||||

